ArticleScientific reports2025
Combined low-intensity pulsed ultrasound and extracorporeal shock wave therapy reduces pain and inflammation in knee osteoarthritis patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined Cupping and Acupuncture Therapy for Dorsocervical Fat Pad: A Series of Case Studies.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Knee Osteoarthritis (KOA) is a degenerative joint condition that leads to pain and limited mobility. Non-invasive treatments like Low-Intensity Pulsed Ultrasound (LIPUS) and Extracorporeal Shockwave Therapy (ESWT) help manage symptoms and support recovery. While both methods are effective, no studies have directly compared ESWT alone to its combination with LIPUS (LESWT, low-intensity pulsed ultrasound + ESWT) for KOA. This study aims to assess their efficacy and provide evidence for treatment choices. The study included 110 patients with KOA who underwent LESWT, forming the LESWT group, and another 110 KOA patients who were treated with ESWT, constituting the ESWT group. Evaluations were conducted to compare clinical outcomes, levels of inflammatory markers in joint synovial fluid, and the occurrence of adverse events before and after the treatment. The LESWT group showed a higher clinical effective rate (87.3%) compared to the ESWT group (73.6%, p < 0.01), with greater improvements in LKSS, Lequesne index, VAS, WOMAC, and ROM scores (p < 0.05). Levels of inflammatory markers (NO, IL-1β, TNF-α, MMP-3) declined, whereas SOD and TGF-β1 levels rose, with the LESWT group exhibiting more pronounced changes (p < 0.01). The occurrence of adverse events showed no significant difference between the groups (p > 0.05). LESWT demonstrates significant efficacy in alleviating pain and reducing inflammatory markers in patients with KOA, making it a promising therapeutic option deserving of further clinical consideration.Trial registration: The study protocol was registered on Chinese Clinical Trial Registry, ChiCTR2457249805. Registered 03/08/2022, https://www.chictr.org.cn/ .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.